Developer docs
API playgroundTry for free, no card

Search company profiles

AdvaMed

Full company profile

uuid0005oqd

Namestring
AdvaMed
Legal namestring
Advanced Medical Technology Association (AdvaMed)
Websiteurl
advamed.org
Company typeenum
Private
Founded yearint
1974
Descriptiontext

AdvaMed (Advanced Medical Technology Association) is a nonprofit trade association founded in 1974 and headquartered in Washington, D.C., that represents over 650 medical technology companies ranging from global multinationals to early-stage startups. The organization operates as the primary U.S. advocacy body for the medtech industry, conducting daily policy representation before the FDA, CMS, EPA, Department of Commerce, and Congress on issues spanning medical device regulation, Medicare coverage and payment, tariffs and trade, cybersecurity, supply chain resilience, and ethical business practices. AdvaMed is structured around specialized divisions — AdvaMedDx for diagnostics, AdvaMed Accel for small and emerging companies (roughly 70% of total membership), AdvaMed Digital Health Tech for AI-enabled and digital health products, and AdvaMed Medical Imaging — supported by more than 100 committees and working groups.

AdvaMed's business model is membership-based: companies pay tiered annual dues (not publicly disclosed, presumably scaled by company size and type) in exchange for access to regulatory expertise, policy advocacy, networking, educational programming, and member-only resources. The organization generates non-dues revenue through flagship events such as The MedTech Conference and the AdvaMed Cybersecurity Summit, the Medtech POV podcast, the Medtech Compliance Workshop, the AdvaMed Code of Ethics certification program (a registered industry standard for HCP interactions), the Medtech Career Center job board, and sponsored partnerships with consulting and law firms. It also operates MedtechVets, a sponsored nonprofit supporting veteran employment in medtech.

Operationally, AdvaMed holds a privileged seat in MDUFA negotiations with the FDA, shapes CMS coverage policy, files amicus briefs on industry-critical litigation such as Walker v. Becton Dickinson, and delivers measurable advocacy outcomes including 2025 wins on EPA ethylene oxide sterilization rules, PFAS legislation across 19 states, diagnostic reimbursement corrections valued at up to $15.5 million annually, and permanent R&D tax relief. Leadership includes President and CEO Scott Whitaker, Board Chair Mick Farrell (CEO of ResMed, January 2026), and division chairs drawn from senior executives at Stryker, Dexcom, Insulet, and Fujifilm SonoSite.

Short descriptiontext

AdvaMed is a nonprofit trade association, founded in 1974 and headquartered in Washington, D.C., representing over 650 medical technology companies through policy advocacy, regulatory representation, specialized divisions, and member services spanning diagnostics, digital health, imaging, and small-company support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWashington, United States
HQ citystring
Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medtech trade association, medical device advocacy, healthcare policy representation, regulatory affairs services, industry membership services
Industry3 codes
1Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
CodeBPADANAJPrimaryYes
2Regulatory Affairs, Labeling & Advertising/Promotion Compliance
CodeHLAJADAIPrimaryNo
3Healthcare & Life Sciences PR
CodeMPAAADADPrimaryNo
NAICS code2 codes
  • Business Associations813910
  • Advertising, Public Relations, and Related Services5418
Product category
Industry Trade Association Services
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Others, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1AdvaMedDx
Description

World leader in advocating for health care policies that support diagnostic testing through robust innovation, timely regulatory approval, appropriate payer coverage, payment rates commensurate with impact on care, and rapid adoption of new, safe and effective diagnostic tests.

advamed.org
+4 more records
Core offering1 text field

AdvaMed (Advanced Medical Technology Association) is a membership-based trade association that advocates for the medical technology industry before federal agencies, Congress, and international bodies. It provides regulatory guidance, reimbursement and coverage advocacy, trade and tariff policy representation, ethical compliance certification, educational programming, networking events, and resource publications for its 650+ member medtech companies. The organization operates through specialized divisions including AdvaMedDx (diagnostics), AdvaMed Accel (small/emerging companies), AdvaMed Digital Health Tech, and AdvaMed Medical Imaging.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • AdvaMed secured rewritten sterilization rules protecting operational capacity for members in 2025
+6 more records
Product overview1 text field

AdvaMed (Advanced Medical Technology Association) is a trade association representing medical technology companies, not a product company itself. AdvaMed does not manufacture or sell medical technology products. The organization provides advocacy, policy representation, educational programs, networking events, and member services for the medtech industry. Its specialized divisions include AdvaMedDx (diagnostics), AdvaMed Accel (small/emerging companies), AdvaMed Digital Health Tech (digital health), and AdvaMed Medical Imaging (imaging sector). Member services include The MedTech Conference, Medtech POV Podcast, Medtech Career Center, Code of Ethics Certification Program, and a Resource Library. As a trade association focused on policy advocacy and industry support rather than product development, AdvaMed has no commercial product portfolio to catalog.

Product and service2 records
1AdvaMed Membership
CategoryTrade Association Membership
Description

Annual corporate membership providing medtech companies access to policy advocacy in Washington D.C., FDA/CMS regulatory engagement, 100+ committees and working groups, member-only resource library, event registration discounts, and networking with industry peers.

2The MedTech Conference
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierNotableTypeStrategic or Co-development Partner
Description

MedTech Innovator is a key ecosystem partner that AdvaMed members engage with. MedTech Innovator runs an annual accelerator program selecting top startups (65 in the 2026 cohort from 1,835 applicants) and connects them with industry mentors, resources, and stakeholders. The program culminates in competitions at The MedTech Conference where companies compete for $800,000 in funding.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

AdvaMed represents the medtech industry in formal negotiations with the FDA on the Medical Device User Fee Amendments (MDUFA VI), covering FDA IT infrastructure upgrades, de novo program changes, pre-submission programs, and fee structures. AdvaMed also works with FDA on cybersecurity frameworks, TAP Pilot, and digital health regulation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

AdvaMed advocates with the Centers for Medicare & Medicaid Services on coverage, coding, and payment policies for medical devices. Key issues include the RAPID pathway for breakthrough devices, TCET rule, NTAP payments, CLFS/PAMA reform, and competitive bidding. AdvaMed supports the Health Tech Investment Act establishing a Medicare reimbursement pathway for AI-enabled devices.

Strategic tierNotableTypeGTM or Marketing Partner
Description

ABHI and AdvaMed both welcomed the MHRA-FDA liaison programme to deepen regulatory cooperation between the UK and US. Both associations noted the initiative would reduce friction for companies seeking market access on both sides of the Atlantic.

Strategic tierMinorTypeGTM or Marketing Partner
Description

BritishAmerican Business joined ABHI and AdvaMed in welcoming the MHRA-FDA liaison programme, noting it would reduce regulatory friction and costs for companies bringing products to market in the UK and US.

Strategic tierNotableTypeImplementation/ SI/ Consulting Partner
Description

AdvaMed hosted a webinar featuring trade law experts from Akin to provide legal and policy analysis on the Supreme Court's IEEPA tariff ruling to help medtech companies respond to these developments and understand refund options.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

AdvaMed submitted formal comments to the U.S. Department of Commerce protesting potential new tariffs on medical devices under Section 232 investigations, emphasizing industry contributions and urging trade policy adjustments that support U.S. medtech production.

Strategic tierNotableTypeImplementation/ SI/ Consulting Partner
Description

AdvaMed partners with Porzio for its annual Medtech Compliance Workshop, a comprehensive two-day program designed to help compliance leaders and legal professionals understand the current medtech compliance framework.

Strategic tierNotableTypeImplementation/ SI/ Consulting Partner
Description

AdvaMed partnered with HealthStream to deliver the AdvaMed Code of Ethics online training course, providing interactive training that equips medtech professionals to apply ethical standards in daily interactions with healthcare professionals.

10119th Congress
Strategic tierCoreTypeOthers
Description

AdvaMed collaborates with leaders and medtech champions from both parties in both houses of the 119th Congress on top medtech priorities including CMS modernization, AI regulation, supply chain resilience, and diagnostic access legislation.

advamed.org
Strategic tierNotableTypeGTM or Marketing Partner
Description

AdvaMed released a video in partnership with Patients Rising explaining the Health Tech Investment Act and what it means for patients, advocating for Medicare coverage of FDA-authorized AI-enabled medical devices.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

MedtechVets is a nonprofit sponsored by AdvaMed that helps veterans find meaningful employment in the medical technology industry by providing personalized career transition services, mentorship, career development guidance, and industry networking.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

AdvaMed hosted a webinar with Kearney exploring how medtech organizations are using AI to transform product development and accelerate innovation.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

AdvaMed hosted a webinar with Alexander Group on Accelerating ASC Transition and Medtech Commercial Model Imperatives, exploring ASC growth trends, buyer dynamics, and go-to-market strategies for medtech manufacturers.

Strategic tierNotableTypeStrategic or Co-development Partner
Description

AdvaMed supports renewal of the USMCA trade agreement, emphasizing its importance for U.S. medtech innovation, supply chain stability, and job creation. The organization works with U.S. authorities on ongoing trade policy cooperation.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

AHA is a broad healthcare industry association representing hospitals and health systems. While its constituency is providers rather than manufacturers, it engages in the same CMS, reimbursement, and regulatory advocacy arena as AdvaMed, often as a counterparty in payment and coverage policy debates.

TypeEmerging player
Description

HIMSS is a global membership organization focused on health information and technology, with overlap to AdvaMed's Digital Health Tech division. Both organizations advocate on AI in healthcare, health data interoperability, and digital medical device policy, competing for digital health member mindshare.

TypeOthers
Description

CMSS is an umbrella organization for U.S. medical specialty societies. While it serves physician societies rather than manufacturers, it is a relevant peer in the broader healthcare advocacy ecosystem and engages on issues like the AdvaMed Code of Ethics governing industry-clinician interactions.

TypeEmerging player
Description

CTA operates the CES consumer electronics show and has expanded into digital health. Its Digital Health Pavilion and health-tech policy work partially overlap with AdvaMed Digital Health Tech, competing for big-tech entrants into healthcare like those represented in AdvaMed's digital health division.

TypeRegional player
Description

ABHI is the UK health technology industry association, serving as AdvaMed's British counterpart. AdvaMed and ABHI have a formal working relationship on transatlantic regulatory issues including the MHRA-FDA liaison programme, making ABHI both a peer and a partner.

TypeEmerging player
Description

AAMI is a standards-development and member-services organization for the medical device and instrumentation community. It complements AdvaMed's advocacy with technical standards work (sterilization, software, cybersecurity) that overlaps with AdvaMed's regulatory and compliance committees.

TypeDirect peer
Description

BIO is the largest U.S. trade association for the biotechnology industry, providing advocacy, policy representation, and member services structurally analogous to AdvaMed's role for medtech. Both organizations engage in MDUFA-adjacent negotiations, lobbying, and large annual conferences serving overlapping life-sciences member companies.

TypeDirect peer
Description

PhRMA is the pharmaceutical industry's primary U.S. trade association, operating a comparable Washington-based advocacy model for its member companies. It shares AdvaMed's structure of regulatory affairs, reimbursement policy, and government affairs divisions serving major life-sciences manufacturers.

TypeDirect peer
Description

MedTech Europe is the European trade association representing medical technology manufacturers, the direct international counterpart to AdvaMed. It covers comparable regulatory (MDR/IVDR), reimbursement, and digital health policy advocacy for medtech companies operating in the EU.

TypeDirect peer
Description

MDMA is a U.S. trade association representing smaller and mid-sized medical device manufacturers. It competes with AdvaMed for the same medtech advocacy mandate but focuses more narrowly on the entrepreneurial and emerging-company segment that AdvaMed Accel also serves.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AdvaMed

Industry Trade Association Servicesadvamed.org

AdvaMed is a nonprofit trade association, founded in 1974 and headquartered in Washington, D.C., representing over 650 medical technology companies through policy advocacy, regulatory representation, specialized divisions, and member services spanning diagnostics, digital health, imaging, and small-company support.

What AdvaMed does

AdvaMed (Advanced Medical Technology Association) is a nonprofit trade association founded in 1974 and headquartered in Washington, D.C., that represents over 650 medical technology companies ranging from global multinationals to early-stage startups. The organization operates as the primary U.S. advocacy body for the medtech industry, conducting daily policy representation before the FDA, CMS, EPA, Department of Commerce, and Congress on issues spanning medical device regulation, Medicare coverage and payment, tariffs and trade, cybersecurity, supply chain resilience, and ethical business practices. AdvaMed is structured around specialized divisions — AdvaMedDx for diagnostics, AdvaMed Accel for small and emerging companies (roughly 70% of total membership), AdvaMed Digital Health Tech for AI-enabled and digital health products, and AdvaMed Medical Imaging — supported by more than 100 committees and working groups.

AdvaMed's business model is membership-based: companies pay tiered annual dues (not publicly disclosed, presumably scaled by company size and type) in exchange for access to regulatory expertise, policy advocacy, networking, educational programming, and member-only resources. The organization generates non-dues revenue through flagship events such as The MedTech Conference and the AdvaMed Cybersecurity Summit, the Medtech POV podcast, the Medtech Compliance Workshop, the AdvaMed Code of Ethics certification program (a registered industry standard for HCP interactions), the Medtech Career Center job board, and sponsored partnerships with consulting and law firms. It also operates MedtechVets, a sponsored nonprofit supporting veteran employment in medtech.

Operationally, AdvaMed holds a privileged seat in MDUFA negotiations with the FDA, shapes CMS coverage policy, files amicus briefs on industry-critical litigation such as Walker v. Becton Dickinson, and delivers measurable advocacy outcomes including 2025 wins on EPA ethylene oxide sterilization rules, PFAS legislation across 19 states, diagnostic reimbursement corrections valued at up to $15.5 million annually, and permanent R&D tax relief. Leadership includes President and CEO Scott Whitaker, Board Chair Mick Farrell (CEO of ResMed, January 2026), and division chairs drawn from senior executives at Stryker, Dexcom, Insulet, and Fujifilm SonoSite.

AdvaMed firmographics

Firmographics
Name
AdvaMed
Legal name
Advanced Medical Technology Association (AdvaMed)
Website
https://advamed.org
Company type
Private
Founded year
1974
Operating status
Operating
Headcount range
101–250 employees
Short description
AdvaMed is a nonprofit trade association, founded in 1974 and headquartered in Washington, D.C., representing over 650 medical technology companies through policy advocacy, regulatory representation, specialized divisions, and member services spanning diagnostics, digital health, imaging, and small-company support.
Ownership category
akta.pro rank

AdvaMed industry classification

Industry
Product category
Industry Trade Association Services
NAICS
Business Associations (813910), Advertising, Public Relations, and Related Services (5418)
akta.pro primary industry
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)
akta.pro secondary industries
Regulatory Affairs, Labeling & Advertising/Promotion Compliance (HLAJADAI), Healthcare & Life Sciences PR (MPAAADAD)

Keywords

  • Medtech trade association
  • Medical device advocacy
  • Healthcare policy representation
  • Regulatory affairs services
  • Industry membership services

Where AdvaMed is headquartered

Location

Headquarters

HQ city
Washington
HQ country
United States
HQ region
North America

Offices1 record

Markets served

AdvaMed business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others, Technology or R&D

Distribution channels4 records

Marketing channels9 records

AdvaMed product offering

Product offering

Core offering

AdvaMed (Advanced Medical Technology Association) is a membership-based trade association that advocates for the medical technology industry before federal agencies, Congress, and international bodies. It provides regulatory guidance, reimbursement and coverage advocacy, trade and tariff policy representation, ethical compliance certification, educational programming, networking events, and resource publications for its 650+ member medtech companies. The organization operates through specialized divisions including AdvaMedDx (diagnostics), AdvaMed Accel (small/emerging companies), AdvaMed Digital Health Tech, and AdvaMed Medical Imaging.

Product overview

AdvaMed (Advanced Medical Technology Association) is a trade association representing medical technology companies, not a product company itself. AdvaMed does not manufacture or sell medical technology products. The organization provides advocacy, policy representation, educational programs, networking events, and member services for the medtech industry. Its specialized divisions include AdvaMedDx (diagnostics), AdvaMed Accel (small/emerging companies), AdvaMed Digital Health Tech (digital health), and AdvaMed Medical Imaging (imaging sector). Member services include The MedTech Conference, Medtech POV Podcast, Medtech Career Center, Code of Ethics Certification Program, and a Resource Library. As a trade association focused on policy advocacy and industry support rather than product development, AdvaMed has no commercial product portfolio to catalog.

Differentiator

Problem solved

Functional benefit

Brands

  • AdvaMedDx: World leader in advocating for health care policies that support diagnostic testing through robust innovation, timely regulatory approval, appropriate payer coverage, payment rates commensurate with impact on care, and rapid adoption of new, safe and effective diagnostic tests.
  • AdvaMed Accel
  • AdvaMed Digital Health Tech
  • AdvaMed Medical Imaging
  • MedtechVets

Products and services

  • AdvaMed Membership Annual corporate membership providing medtech companies access to policy advocacy in Washington D.C., FDA/CMS regulatory engagement, 100+ committees and working groups, member-only resource library, event registration discounts, and networking with industry peers.
  • The MedTech Conference

Quantifiable outcome

  • AdvaMed secured rewritten sterilization rules protecting operational capacity for members in 2025
  • +6 more outcomes

Companies that use AdvaMed

Customer profile

Named customers13 records

Segments7 records

Ideal customer profiles2 records

AdvaMed technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AdvaMed partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered notable, core and minor.

  • MedTech InnovatornotableStrategic or Co-development PartnerMedTech Innovator is a key ecosystem partner that AdvaMed members engage with. MedTech Innovator runs an annual accelerator program selecting top startups (65 in the 2026 cohort from 1,835 applicants) and connects them with industry mentors, resources, and stakeholders. The program culminates in competitions at The MedTech Conference where companies compete for $800,000 in funding.
  • FDAcoreStrategic or Co-development PartnerAdvaMed represents the medtech industry in formal negotiations with the FDA on the Medical Device User Fee Amendments (MDUFA VI), covering FDA IT infrastructure upgrades, de novo program changes, pre-submission programs, and fee structures. AdvaMed also works with FDA on cybersecurity frameworks, TAP Pilot, and digital health regulation.
  • CMScoreStrategic or Co-development PartnerAdvaMed advocates with the Centers for Medicare & Medicaid Services on coverage, coding, and payment policies for medical devices. Key issues include the RAPID pathway for breakthrough devices, TCET rule, NTAP payments, CLFS/PAMA reform, and competitive bidding. AdvaMed supports the Health Tech Investment Act establishing a Medicare reimbursement pathway for AI-enabled devices.
  • ABHI (Association of British Health-Tech Industries)notableGTM or Marketing PartnerABHI and AdvaMed both welcomed the MHRA-FDA liaison programme to deepen regulatory cooperation between the UK and US. Both associations noted the initiative would reduce friction for companies seeking market access on both sides of the Atlantic.
  • BritishAmerican BusinessminorGTM or Marketing PartnerBritishAmerican Business joined ABHI and AdvaMed in welcoming the MHRA-FDA liaison programme, noting it would reduce regulatory friction and costs for companies bringing products to market in the UK and US.
  • Akin (law firm)notableImplementation/ SI/ Consulting PartnerAdvaMed hosted a webinar featuring trade law experts from Akin to provide legal and policy analysis on the Supreme Court's IEEPA tariff ruling to help medtech companies respond to these developments and understand refund options.
  • U.S. Department of CommercecoreStrategic or Co-development PartnerAdvaMed submitted formal comments to the U.S. Department of Commerce protesting potential new tariffs on medical devices under Section 232 investigations, emphasizing industry contributions and urging trade policy adjustments that support U.S. medtech production.
  • Porzio (compliance services)notableImplementation/ SI/ Consulting PartnerAdvaMed partners with Porzio for its annual Medtech Compliance Workshop, a comprehensive two-day program designed to help compliance leaders and legal professionals understand the current medtech compliance framework.
  • HealthStream (training)notableImplementation/ SI/ Consulting PartnerAdvaMed partnered with HealthStream to deliver the AdvaMed Code of Ethics online training course, providing interactive training that equips medtech professionals to apply ethical standards in daily interactions with healthcare professionals.
  • 119th CongresscoreOthersAdvaMed collaborates with leaders and medtech champions from both parties in both houses of the 119th Congress on top medtech priorities including CMS modernization, AI regulation, supply chain resilience, and diagnostic access legislation.
  • Patients Rising (patient advocacy)notableGTM or Marketing PartnerAdvaMed released a video in partnership with Patients Rising explaining the Health Tech Investment Act and what it means for patients, advocating for Medicare coverage of FDA-authorized AI-enabled medical devices.
  • MedtechVets (nonprofit)minorStrategic or Co-development PartnerMedtechVets is a nonprofit sponsored by AdvaMed that helps veterans find meaningful employment in the medical technology industry by providing personalized career transition services, mentorship, career development guidance, and industry networking.
  • Kearney (strategy consulting)minorImplementation/ SI/ Consulting PartnerAdvaMed hosted a webinar with Kearney exploring how medtech organizations are using AI to transform product development and accelerate innovation.
  • Alexander Group (revenue consulting)minorImplementation/ SI/ Consulting PartnerAdvaMed hosted a webinar with Alexander Group on Accelerating ASC Transition and Medtech Commercial Model Imperatives, exploring ASC growth trends, buyer dynamics, and go-to-market strategies for medtech manufacturers.
  • USMCA Trade PartnersnotableStrategic or Co-development PartnerAdvaMed supports renewal of the USMCA trade agreement, emphasizing its importance for U.S. medtech innovation, supply chain stability, and job creation. The organization works with U.S. authorities on ongoing trade policy cooperation.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

AdvaMed competitors and assessment

Company assessment

Broad incumbents

  • American Hospital Association (AHA): AHA is a broad healthcare industry association representing hospitals and health systems. While its constituency is providers rather than manufacturers, it engages in the same CMS, reimbursement, and regulatory advocacy arena as AdvaMed, often as a counterparty in payment and coverage policy debates.

Emerging players

  • HIMSS (Healthcare Information and Management Systems Society): HIMSS is a global membership organization focused on health information and technology, with overlap to AdvaMed's Digital Health Tech division. Both organizations advocate on AI in healthcare, health data interoperability, and digital medical device policy, competing for digital health member mindshare.
  • Consumer Technology Association (CTA): CTA operates the CES consumer electronics show and has expanded into digital health. Its Digital Health Pavilion and health-tech policy work partially overlap with AdvaMed Digital Health Tech, competing for big-tech entrants into healthcare like those represented in AdvaMed's digital health division.
  • Association for the Advancement of Medical Instrumentation (AAMI): AAMI is a standards-development and member-services organization for the medical device and instrumentation community. It complements AdvaMed's advocacy with technical standards work (sterilization, software, cybersecurity) that overlaps with AdvaMed's regulatory and compliance committees.

Others

  • Council of Medical Specialty Societies (CMSS): CMSS is an umbrella organization for U.S. medical specialty societies. While it serves physician societies rather than manufacturers, it is a relevant peer in the broader healthcare advocacy ecosystem and engages on issues like the AdvaMed Code of Ethics governing industry-clinician interactions.

Regional players

  • Association of British Health-Tech Industries (ABHI): ABHI is the UK health technology industry association, serving as AdvaMed's British counterpart. AdvaMed and ABHI have a formal working relationship on transatlantic regulatory issues including the MHRA-FDA liaison programme, making ABHI both a peer and a partner.

Direct peers

  • Biotechnology Innovation Organization (BIO): BIO is the largest U.S. trade association for the biotechnology industry, providing advocacy, policy representation, and member services structurally analogous to AdvaMed's role for medtech. Both organizations engage in MDUFA-adjacent negotiations, lobbying, and large annual conferences serving overlapping life-sciences member companies.
  • PhRMA: PhRMA is the pharmaceutical industry's primary U.S. trade association, operating a comparable Washington-based advocacy model for its member companies. It shares AdvaMed's structure of regulatory affairs, reimbursement policy, and government affairs divisions serving major life-sciences manufacturers.
  • MedTech Europe: MedTech Europe is the European trade association representing medical technology manufacturers, the direct international counterpart to AdvaMed. It covers comparable regulatory (MDR/IVDR), reimbursement, and digital health policy advocacy for medtech companies operating in the EU.
  • Medical Device Manufacturers Association (MDMA): MDMA is a U.S. trade association representing smaller and mid-sized medical device manufacturers. It competes with AdvaMed for the same medtech advocacy mandate but focuses more narrowly on the entrepreneurial and emerging-company segment that AdvaMed Accel also serves.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

AdvaMed social profiles

Digital presence

AdvaMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AdvaMed leadership team

Management profile

Number of profiles

Profiles1 record

AdvaMed subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

AdvaMed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AdvaMed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AdvaMed

What does AdvaMed do?

AdvaMed (Advanced Medical Technology Association) is a membership-based trade association that advocates for the medical technology industry before federal agencies, Congress, and international bodies. It provides regulatory guidance, reimbursement and coverage advocacy, trade and tariff policy representation, ethical compliance certification, educational programming, networking events, and resource publications for its 650+ member medtech companies. The organization operates through specialized divisions including AdvaMedDx (diagnostics), AdvaMed Accel (small/emerging companies), AdvaMed Digital Health Tech, and AdvaMed Medical Imaging.

Is AdvaMed a public or private company?

AdvaMed is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was AdvaMed founded?

AdvaMed was founded in 1974. It employs 101 to 250 people.

Where is AdvaMed based?

AdvaMed is headquartered in Washington, United States, in the North America region.

Who are AdvaMed's main competitors?

American Hospital Association (AHA) is listed as a broad incumbent. Emerging players are HIMSS (Healthcare Information and Management Systems Society), Consumer Technology Association (CTA) and Association for the Advancement of Medical Instrumentation (AAMI). Council of Medical Specialty Societies (CMSS) is listed as an others. Association of British Health-Tech Industries (ABHI) is listed as a regional player. Direct peers are Biotechnology Innovation Organization (BIO), PhRMA, MedTech Europe and Medical Device Manufacturers Association (MDMA).

Does AdvaMed have an API?

No public API is recorded for AdvaMed.

What industry is AdvaMed in?

AdvaMed's product category is Industry Trade Association Services. Its primary akta.pro industry code is BPADANAJ, Health, Pharmaceuticals & Medical Devices Regulatory Cooperation, with a secondary code of HLAJADAI, Regulatory Affairs, Labeling & Advertising/Promotion Compliance. Its NAICS code is 813910.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MedTech DiveMedtech lobby seeks broader device eligibility for CMS’ proposed RAPID pathwayAdvaMed urged CMS to broaden device eligibility for the RAPID pathway, which would give certain breakthrough devices a proposed national coverage determination after FDA authorization. The program expects 40 devices to qualify, with 20 more possible, and AdvaMed called for clearer timelines and diagnostics inclusion. CMS is accepting public comments through Oct. 13.YahooMedtech lobby seeks broader device eligibility for CMS’ proposed RAPID pathwayAdvaMed urged CMS to broaden device eligibility for the RAPID pathway, which would give FDA-authorized breakthrough devices a national coverage determination. The program expects 40 devices to qualify now, with 20 more possible, and AdvaMed wants clearer timelines and diagnostics inclusion. CMS is accepting public comments through Oct. 13.American City Business JournalsDigital Marketing Agency BizSpotlightBrick Marketing, a digital marketing agency based in Boston, will exhibit at The MedTech Conference hosted by AdvaMed from October 18 through October 21, 2026. The company aims to discuss marketing strategies and growth opportunities with medical technology leaders, investors, and industry partners at Booth 637.AdvamedInvesting in Women’s Health Products and CompaniesAdvaMed is hosting the second webinar in its 2026 Women’s Health series, developed in partnership with the Medtech Investment Working Group, to explore investment strategies and market dynamics for women’s health products. The event features a panel of industry leaders from organizations such as Intuitive Ventures, Novocuff, and American Heart Association Ventures to discuss successes and challenges in the sector.AdvamedAdvaMed Strongly Supports Draft MDUFA VI Agreement at FDA Public MeetingAdvaMed expressed strong support for the draft Medical Device User Fee Amendments (MDUFA) VI agreement at an FDA public hearing in Washington, D.C. The agreement aims to build on existing measures, make practical improvements, and support timely patient access to medical technology.AdvamedEssential Tremor Treatment: A Sensible Solution, Possibly Driven Out of ReachEncora Therapeutics received FDA authorization for its X1 wearable device to treat essential tremor, but faces enrollment barriers due to a six-month moratorium on new DMEPOS provider registrations issued by the Centers for Medicare and Medicaid Services (CMS). This regulatory block prevents Encora from billing Medicare directly, forcing reliance on third-party distributors that may compromise the company's direct patient support model. AdvaMed has urged CMS to address these unintended consequences to avoid stifling innovation in medical technology.UK GovernmentUnique liaison programme set to reinforce close collaboration between MHRA and FDAThe UK Medicines and Healthcare products Regulatory Agency (MHRA) and the US Food and Drug Administration (FDA) have announced a new liaison programme to deepen regulatory cooperation, establishing reciprocal liaison officer roles within each organization. The programme aims to accelerate product approvals for innovative medicines, medical devices, and emerging technologies like AI by enabling faster, more coordinated regulatory approaches while maintaining both agencies' full independence. Industry groups including the ABHI, AdvaMed, and BritishAmerican Business welcomed the initiative, noting it will reduce friction for companies seeking market access on both sides of the Atlantic.Mirage NewsMHRA-FDA Liaison Programme to Boost CollaborationThe UK Medicines and Healthcare products Regulatory Agency (MHRA) and the US Food and Drug Administration (FDA) have announced a new reciprocal liaison programme at the DIA Global Annual Meeting in Philadelphia, establishing dedicated officer roles within each agency to strengthen regulatory collaboration. The programme aims to deepen cooperation across innovative medicines, medical devices, and emerging technologies such as AI, while both agencies maintain full regulatory independence and continue making independent decisions. Industry associations including the ABHI, AdvaMed, and BritishAmerican Business have welcomed the initiative, noting it will reduce regulatory friction and costs for companies seeking to bring products to market in both the UK and US.AdvamedAdvaMed® Welcomes Senate Introduction of Bipartisan Medical Device Electronic Labeling BillSenators Jim Banks and John Hickenlooper introduced the bipartisan Medical Device Electronic Labeling Act (S. 4519) in the Senate, which would allow medtech manufacturers to provide instructions for use electronically instead of paper copies. AdvaMed, the world's largest medtech trade association, welcomed the legislation, citing benefits including faster safety updates, improved accessibility for patients with visual impairments, and the ability to integrate instructional videos and interactive content. The bill mirrors similar legislation (H.R. 1539) introduced in the House last year, with AdvaMed expressing hope both bills can be passed and signed into law this year.AdvamedEarlier Answers, Better Care: How Expanded Access to Alzheimer’s Testing Can Change LivesAdvaMed advocated for Medicare reimbursement for Alzheimer's biomarker tests, leading to a policy change effective January 2026 that allows more providers to offer them. The advocacy aimed to support earlier diagnosis for the over 6 million Americans living with Alzheimer's, projected to reach 8.5 million by 2030.